
Kleanthis G. Xanthopoulos, Ph.D.
Chairman & Chief Executive Officer

STEVEN HOLTZMAN
Co-Founder & Director

Marios Fotiadis
Director
To advance transformative therapies for autoimmune disease and cancer
To develop the right cell, with the right edits, for the right indications
Chief Medical Officer
Chief Business Officer
Vice President, Controller
Vice President, Translational Pharmacology
Senior Vice President, Research
Chairman & Chief Executive Officer
Chairman & Chief Executive Officer
Co-Founder & Director
Director
Director
Director
Co-Founder & Advisory Board Member
Advisory Board Member